KC Care health Center
Kansas City, Missouri 64124
2 studies enrolling now · 10 studies all time
What they study most
ART, HIV Infections, HIV-1-Infection, HIV-1-infection, Noncompliance, Patient, Pre-Exposure Prophylaxis of HIV Infection
Studies at this site
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 — Recruiting now
- Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention — Recruiting now
- Accelerated ART Initiation for PWHIV Who Are Out of Care — Running, not enrolling
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy — Running, not enrolling
- Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence — Completed
- Study of GS-3242 in Participants With HIV-1; Substudy-05 — Completed
- Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 — Running, not enrolling
- Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed — Running, not enrolling
- Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection — Running, not enrolling
- Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV — Completed